Fair value · InflaRx N.V. (IFRX) · updated 2026-10-03 · from annual report FY2025
InflaRx trades at $1.72. We are not reading assumptions out of that price: financials are filed in EUR; our prices are in USD, so these methods need a conversion we do not yet publish.
Everything below is unaffected: the filed statements, the filing they came from, and IFRX’s growth history are all as reported.
The filing behind these numbers
InflaRx N.V.- Revenue
- EUR 29331
- Diluted EPS
- EUR -0.68
- Free cash flow
- EUR -35.4M
- operating cash flow − capital expenditure
- Diluted shares
- 67.3M
- weighted average
annual report FY2025 · fiscal year ended 2025-12-31 · filed 2026-03-20 · accession 0001213900-26-032065
Open this filing on sec.govNeed IFRX data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.